A Phase 3 Study To Compare The Efficacy And Safety Of 0.3 MG Pegaptanib Sodium To Sham Injections In Subjects With Diabetic Macular Edema
Condition(s):Macular Edema; Diabetic Mellitus; Retinal DiseaseLast Updated:August 23, 2013Completed
Hide Studies Not Open or Pending
Condition(s):Macular Edema; Diabetic Mellitus; Retinal DiseaseLast Updated:August 23, 2013Completed
Condition(s):Symptomatic Vitreomacular AdhesionLast Updated:November 30, 2015Completed
Condition(s):Diabetic Macular EdemaLast Updated:December 17, 2014Completed
Condition(s):Dry Age-related Macular Degeneration; Geographic Atrophy; Gene Therapy; Intravitreal InjectionLast Updated:May 10, 2021Withdrawn
Condition(s):Neck Pain, Posterior; Pain, AcuteLast Updated:August 8, 2018Completed
Condition(s):Knee OsteoarthritisLast Updated:April 21, 2017Terminated
Condition(s):Type 1 Diabetes MellitusLast Updated:February 1, 2019Completed
Condition(s):Exudative Age-Related Macular Degeneration; Focal Vitreomacular AdhesionLast Updated:December 17, 2014Completed
Condition(s):Macular Edema; Retinal Vein OcclusionLast Updated:July 28, 2017Completed
Condition(s):Geographic AtrophyLast Updated:June 18, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.